Best Life Sciences Tech Companies in North Carolina, United States
The 79 best Life Sciences Tech companies in North Carolina, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: GenetronHealth.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in North Carolina
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | GenetronHealth Provider of services in the development of precision medicine tools for cancer treatment | $191M | 79 mo ago | 993 | 2013 | Sizhen Wang Co-Founder & CEO | BootstrapNginxSwiper+6 | — | 1 launch |
| 2 | SignalPath Clinical trial management system to streamline research and maximize revenue | $36M | 79 mo ago | 100 | 2014 | — | — | 5 patents Real-time process control modeling with sequence and time anchoring for industrial automation | — |
| 3 | Topography Health The company provides a full-stack clinical trials platform for community physicians | $28M | 53 mo ago | 12 | 2020 | Andrew Kirchner Co-Founder | — | — | — |
| 4 | Codetta Online platform for analyzing omics clinical data | $27M | 25 mo ago | 21 | 2021 | — | — | — | — |
| 5 | Reactive Biosciences Developer of boron-based medicines for various disease conditions | $23M | 16 mo ago | — | 2021 | Julie Grant CEO | — | — | — |
| 6 | Ten63 Developer of therapeutics for undruggable targets 21Talent top 28%Funding top 32%Moat top 35%News top 44% All 7 signals ▾Talenttop 28% Fundingtop 32% Moattop 35% Newstop 44% Globalbottom 39% Techbottom 26% Marketbottom 24% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated Funding: Raised $18.3M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) rank vs industry peers · Fliar Intelligence Index 21/100 | $18M | 4 mo ago | 10 | 2019 | Mark Hallen Co-Founder & CTO | WordPressMySQLPHP+13 | — | — |
| 7 | Clinverse Cloud-based financial lifecycle system for automating clinical payments for the clinical trials industry. | $16M | 142 mo ago | 51 | 2008 | — | — | 4 patents Healthcare payment network for clinical services and billing integration | — |
| 8 | Clinical Ink Clinical trial solutions provider specializing in eSource technology and patient-centric research | $15M | 97 mo ago | 283 283 → 331 (+17%) | 2006 | Jonathan Goldman CEO | WordPressApple iCloud MailMySQL+31 | — | 7 job openings · 1 internship |
| 9 | Clinetic Provider of data analysis and diagnostic tools for clinical trial professionals | $11M | 34 mo ago | 17 | 2017 | Erich Huang Md Founder | — | — | — |
| 10 | Lindy Biosciences Developer of formulation technology for bio-therapeutics drug delivery | $7M | 27 mo ago | 4 | 2016 | — | — | — | — |
| 11 | Avicenna Provider of drug development solutions | $6M | 23 mo ago | — | 2020 | Pieter Burger Co-Founder | — | — | — |
| 12 | Gusto Global Developer of microbiome technology to detect infectious diseases | $6M | 45 mo ago | 4 | 2015 | — | — | 30 patents Microbial diagnostics and therapeutics via targeted amplicon sequencing and EV RNA analysis | — |
| 13 | Amissa Developer of a wearable-based data collection solutions for the prediction, early identification, and… | $5M | 10 mo ago | 7 | 2017 | Jon Corkey Founder & CEO | ContentfulTurbopackNode.js+12 | — | — |
| 14 | Alleviate Health Provider of AI-powered platform for clinical research participant recruitment workflows | $4M | 8 mo ago | — | 2023 | Saathvik Boompelli Co-Founder | — | — | — |
| 15 | Cloud Pharma AI-powered drug discovery and development transforming healthcare with generative AI | $3M | 131 mo ago | 5 | 2009 | — | — | — | — |
| 16 | EmergingMed Cloud based platform to match patients with clinical trials. | $3M | 245 mo ago | 13 | 2000 | Courtney Hudson Founder & CEO | AngularJSLodashjQuery+5 | — | — |
| 17 | Dendi Provider of laboratory automation solutions for performing routine tasks in laboratories | $2M | 46 mo ago | 21 | 2018 | Jihoon Baek Co-Founder & CEO | — | — | 1 partnership |
| 18 | Polaris Quantum Biotech Developer of a AI and quantum computing-based drug discovery platform | $2M | 58 mo ago | 13 13 → 9 (-31%) | 2019 | Bill Shipman Co-Founder | — | — | — |
| 19 | IQVIA Provider of clinical research and commercialization solutions for healthcare | $2M | 30 mo ago | 87,000 87,000 → 80,769 (-7%) | 1982 | Luciano Catoni Founder | WordPressApple iCloud MailMicrosoft 365+35 | 219 patents Health data analytics and AI-driven clinical trial design, monitoring, and regulatory intelligence. | 1 partnership |
| 20 | DILIsym Provider of quantitative toxicology software for the drug development process | $2M | 89 mo ago | — | 2014 | Brett Howell CEO & President | — | — | — |
| 21 | CertiRx Serialization security platform and platform technology to detect counterfeits and frauds. | $841K | 128 mo ago | — | 2011 | Hersh Tapadia Co-Founder | — | 16 patents Secure identity verification and anti-counterfeiting via digital, biometric, and molecular tagging | — |
| 22 | Base4 Developer of RNA-modulating small molecule drugs for multiple diseases | $550K | 68 mo ago | — | 2009 | Joshua Fairbank Founder & CEO | — | 14 patents Provides anti‑flare cookware and grill accessories such as pans, trivet and docking systems. | — |
| 23 | Acorn Applications Cloud-Based Analytic Clinical Research Solutions | $500K | 132 mo ago | — | 2013 | Gordon Jones Founder & CEO | — | — | — |
| 24 | RedOak Logic Develops decision modeling support platform and application interface for drug development industry | $250K | 186 mo ago | — | 2009 | Dale Fedewa Founder | — | — | — |
Top 12 Life Sciences Tech companies in North Carolina
#1
Series A · Durham, North Carolina · founded 2019 · 10 employees$18.3Mraised▾
Ten63 is a developer of drugs that target undruggable protein targets. The company is developing therapeutics through its platform called COPPER that uses proprietary AI technology and physical models to explore the protein chemical space and screen a large dataset of molecules to identify binding sites.
- Feb 2026Series A—
- May 2023Series A$15.9M
- Jan 2021Seed$2.1M
- 2019Seed$250K
#2
Seed · Durham, North Carolina · founded 2023$4.3Mraised▾
Provider of AI-powered platform for clinical research participant recruitment workflows. The platform offers conversational engagement at scale, responding to participants quickly. It uses a library of conversations to maximize response rates. The platform adapts to different study requirements and indications. It facilitates pre-screening conversations via SMS and AI voice calls.
- Oct 2025Seed$4.3M
#3
Series A · Durham, North Carolina · founded 2021$23.5Mraised▾
Developer of boron-based medicines for various disease conditions. The company uses computational methods and a boron-based discovery platform to discover and develop drugs for undruggable targets.
- Feb 2025Grant (prize money)$464.5K
- Jan 2025Grant (prize money)$464.5K
- Jun 2023Conventional Debt$4M
- Sep 2022Series A$23.5M
#4
Funding Raised · Charlotte, North Carolina · founded 2017 · 7 employees$4.9Mraised▾
Developer of a wearable-based data collection solutions for the prediction, early identification, and prevention of dementias and other health conditions. The wearable data collection technology enables researchers and clinicians to gather real-world data to improve healthcare outcomes. It monitor compliance and send notifications to ensure adherence, analyse data, and share results.
- Aug 2025Grant (prize money)$2.5M
- Sep 2024Grant (prize money)$505.5K
- Sep 2021Grant (prize money)$1.9M
#5
Series A · Morrisville, North Carolina · founded 2021 · 21 employees$27.3Mraised▾
Online platform for analyzing omics clinical data. The platform offers analysis of reagents, hardware, and software enabling simultaneous, multiplexed, and multi-omic analyses of liquid biopsy and isolated DNA, RNA, and protein.
- May 2024Series A$12.3M
- Apr 2022Series A$15M
#6
Funding Raised · Durham, North Carolina · founded 2020$6Mraised▾
Provider of drug development solutions. It uses machine learning enhanced medicinal chemistry to accelerate the lead to candidate optimization process for small molecule drug development. It provides solutions to predict quantitative structure activity relationships and other properties of drug candidates.
- Jul 2024Conventional Debt$6M
#7
Seed · Durham, North Carolina · founded 2016 · 15 employees$90Kraised▾
ScitoVation engages in offering chemical compound safety tools for the healthcare, cosmetic, and food industry. The company provides services in the mode of action of a chemical, extrapolation of the animal to human exposure, and the use of gene expression and sequencing data to ascertain toxicity. The company develops and applies technology to model scenarios and environments unique to chemical toxicity and gene expression data. These include PLETHEM (Population Lifecourse Exposure-To-Health-Effects Model Suite) a modular design platform that supports a variety of exposure and PBPK models and MoAviz which is a browser-based applet for summarizing, exploring and interpreting gene expression and other high-throughput data. The product developed by the company for transcriptomics analysis is ScitoXpress.
- Sep 2025Grant (prize money)$973.3K
- May 2025Grant (prize money)$973.3K
- Jul 2023Grant (prize money)$270K
- May 2023Grant (prize money)$1.8M
#8
Series B · Durham, North Carolina · founded 2016 · 4 employees$7.3Mraised▾
Developer of formulation technology for bio-therapeutics drug delivery. Our core technology produces spherical, dense, stable particles of a therapeutic protein that are suitable for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), and encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
- Mar 2024Series B$1.7M
- Mar 2022Series B$3.2M
- 2020Series A$1.6M
- Jan 2019Seed$547.7K
#9
Public · Durham, North Carolina · founded 2013 · 993 employees$191.1Mraised▾
Provider of services in the development of precision medicine tools for cancer treatment. It focused on providing precision medicine tools for cancer treatment. It assists medical practitioners and researchers with a complete cycle of solutions for cancer treatment and management such as risk assessment, molecular pathology, the medication guide, and prognostic monitoring. The company's other products include gene analysis, molecular detection, gene test and sequencing, and genetic screening.
- Nov 2019Series D$71.1M
- Sep 2018Series C$58.4M
- Jan 2018Series C$61.5M
- Sep 2016Series B—
#10
Acquired · Raleigh, North Carolina · founded 2017 · 17 employees$11.4Mraised▾
Provider of data analysis and diagnostic tools for clinical trial professionals. The company has designed a real-time patients EHR data analysis platform for clinical research and development. The software assists with the diagnostics, treatments, and care decisions process by using the clinical surveillance activities analysis tool. The platform has the ability to connect with the EHR system in order to undergo data trials, disease surveillance, and quality improvement programs. The process can be further used to identify patients eligible for a clinical trial study.
- Aug 2023Series A$5M
- Feb 2021Series A$6.4M
#11
Series A · Wilmington, North Carolina · founded 2020 · 12 employees$27.5Mraised▾
Topography is a full-stack, white-glove clinical trials product and service experience that identifies, trains, and supports community physicians in expanding their clinical research capabilities and scaling clinical trials in their communities. Topography is creating a national network of community physicians to expand access to clinical drug trials.
- Jan 2022Series A$21.5M
- 2020Seed$6M
#12
Acquired · Durham, North Carolina · founded 2014 · 100 employees$35.6Mraised▾
Clinical trial management system to streamline research and maximize revenue. This solution suite empowers clinical research with advanced technology. It alleviates research gridlock and burnout with a user-friendly, state-of-the-art clinical trial management system (CTMS). Designed for enterprise research sites, it digitizes study protocols and eliminates siloed manual processes to enable more efficient research and higher-quality output. The platform offers protocol digitization, converting static PDF study protocols into dynamic, digital data models. It maximizes research revenue with real-time metrics and sophisticated dashboards to analyze revenue, costs, and profitability. Integrations across eClinical solutions, such as EHRs and eRegulatory binders, reduce complexity and improve productivity. The system supports all site stakeholders, freeing researchers to focus on research with next-gen CTMS features. It is a SaaS, Software solution.
- Nov 2019Series B$18.2M
- Jan 2018Series A$8M
- Jan 2017Series A$5M
- Feb 2016Seed$3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.